Search

everythinglearnresearchcommunity

for

Search:↓

Using Decamethoxine and Blastomunil together speeds up wound healing.

Pre-surgical embolization and a two-stage resection improve outcomes for rare sacral tumors.

A multidisciplinary approach is crucial for managing Silver-Russell syndrome effectively.

Countries should improve sex education, access to contraception, and legal abortion options.

Rhabdomyosarcoma is the most common head and neck cancer in children, requiring complex treatment.

Comprehensive treatment improved hearing in 89.7% of soldiers with blast-induced hearing loss.

Ancient immune and signaling pathways still regulate blood cell development.

Virtual surgical planning improves efficiency, coordination, and precision in complex surgeries.

The formulated gel is a promising treatment for alopecia areata.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

Local antibiotic therapy can effectively treat root canal infections.

The model and estimator can predict drug exposure in kidney transplant patients well.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Alopecia areata leads to significantly higher healthcare costs due to more doctor visits and prescriptions.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Alopecia areata affects quality of life more in adolescents than adults.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Personalized care and evidence-based treatments are crucial for managing skin and hair conditions.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Doctors in the Middle East need better treatments and more knowledge about new therapies for hair loss condition Alopecia Areata.

Alopecia areata causes sudden hair loss, has genetic links, and can be managed but not cured.

Using a combination of specific cell cycle regulators is better for safely keeping hair root cells alive indefinitely compared to cancer-related methods.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Rituximab can cause skin issues, but baricitinib may help improve them.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

Baricitinib is more effective than methotrexate for severe alopecia areata.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.